POPS RICHARD F Insider Trades

Insider Trading History

Track insider trading activity for POPS RICHARD F. See latest buy and sell transactions across all companies.

Holdings

Company
Holding Value
Last Transaction
Sale/Purchase
Amount
Price
Current Price

Insider Trades History

Company
Holding Value
Last Transaction
Sale/Purchase
Amount
Price
Current Price
Neurocrine Biosciences
Neurocrine Biosciences NBIX
Director
Holding Value $414k 2,567 shares
Last Trade
May 27, 2026 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$400k 2,567 shares
$155.83
$161.44
Neurocrine Biosciences
Neurocrine Biosciences NBIX
Director
Holding Value $0 0 shares
Last Trade
May 21, 2026 Sale (Option Exercise)Shares acquired or sold by exercising stock options or converting another derivative security.
$516k 3,318 shares
$155.50
$161.44
Neurocrine Biosciences
Neurocrine Biosciences NBIX
Director
Holding Value $6.1M 37,798 shares
Last Trade
May 21, 2026 Purchase (Option Exercise)Shares acquired or sold by exercising stock options or converting another derivative security.
$516k 3,318 shares
$155.50
$161.44
Neurocrine Biosciences
Neurocrine Biosciences NBIX
Director
Holding Value $5.57M 34,480 shares
Last Trade
May 15, 2026 Sale (Open Market)Shares sold on the open market or in a private sale.
$2.36M 15,000 shares
$157.65
$161.44
Neurocrine Biosciences
Neurocrine Biosciences NBIX
Director
Holding Value $0 0 shares
Last Trade
May 15, 2026 Sale (Option Exercise)Shares acquired or sold by exercising stock options or converting another derivative security.
$2.38M 15,000 shares
$158.42
$161.44
Neurocrine Biosciences
Neurocrine Biosciences NBIX
Director
Holding Value $7.99M 49,480 shares
Last Trade
May 15, 2026 Purchase (Option Exercise)Shares acquired or sold by exercising stock options or converting another derivative security.
$2.38M 15,000 shares
$158.42
$161.44
Alkermes plc
Alkermes plc ALKS
Director And Ceo, Alkermes Plc
Holding Value $4.27M 88,843 shares
Last Trade
Mar 02, 2026 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$2.69M 88,843 shares
$30.25
$48.07
Alkermes plc
Alkermes plc ALKS
Director And Ceo, Alkermes Plc
Holding Value $66.2M 1,377,740 shares
Last Trade
Feb 05, 2026 Sale (In-Kind)Shares used to pay exercise costs or tax withholding, or another in-kind transfer tied to compensation.
$2.09M 62,230 shares
$33.55
$48.07
Alkermes plc
Alkermes plc ALKS
Director And Ceo, Alkermes Plc
Holding Value $69.2M 1,439,970 shares
Last Trade
Feb 05, 2026 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$5.02M 149,580 shares
$33.55
$48.07
Neurocrine Biosciences
Neurocrine Biosciences NBIX
Director
Holding Value $0 0 shares
Last Trade
May 22, 2025 Sale (Option Exercise)Shares acquired or sold by exercising stock options or converting another derivative security.
$342k 2,869 shares
$119.12
$161.44
Neurocrine Biosciences
Neurocrine Biosciences NBIX
Director
Holding Value $5.57M 34,480 shares
Last Trade
May 22, 2025 Purchase (Option Exercise)Shares acquired or sold by exercising stock options or converting another derivative security.
$342k 2,869 shares
$119.12
$161.44
Neurocrine Biosciences
Neurocrine Biosciences NBIX
Director
Holding Value $536k 3,318 shares
Last Trade
May 21, 2025 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$400k 3,318 shares
$120.56
$161.44
Alkermes plc
Alkermes plc ALKS
Director And Ceo, Alkermes Plc
Holding Value $14.1M 293,921 shares
Last Trade
Feb 19, 2025 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$10.5M 293,921 shares
$35.84
$48.07
Alkermes plc
Alkermes plc ALKS
Director And Ceo, Alkermes Plc
Holding Value $65.9M 1,370,315 shares
Last Trade
Feb 06, 2025 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$5.98M 190,640 shares
$31.39
$48.07
Alkermes plc
Alkermes plc ALKS
Director And Ceo, Alkermes Plc
Holding Value $62M 1,290,390 shares
Last Trade
Feb 06, 2025 Sale (In-Kind)Shares used to pay exercise costs or tax withholding, or another in-kind transfer tied to compensation.
$2.51M 79,925 shares
$31.39
$48.07
Neurocrine Biosciences
Neurocrine Biosciences NBIX
Director
Holding Value $463k 2,869 shares
Last Trade
May 22, 2024 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$400k 2,869 shares
$139.43
$161.44
Neurocrine Biosciences
Neurocrine Biosciences NBIX
Director
Holding Value $5.44M 33,711 shares
Last Trade
May 17, 2024 Purchase (Option Exercise)Shares acquired or sold by exercising stock options or converting another derivative security.
$597k 4,199 shares
$142.29
$161.44
Neurocrine Biosciences
Neurocrine Biosciences NBIX
Director
Holding Value $5.1M 31,611 shares
Last Trade
May 17, 2024 Sale (Open Market)Shares sold on the open market or in a private sale.
$298k 2,100 shares
$141.84
$161.44
Neurocrine Biosciences
Neurocrine Biosciences NBIX
Director
Holding Value $0 0 shares
Last Trade
May 17, 2024 Sale (Option Exercise)Shares acquired or sold by exercising stock options or converting another derivative security.
$597k 4,199 shares
$142.29
$161.44
Neurocrine Biosciences
Neurocrine Biosciences NBIX
Director
Holding Value $8.51M 52,712 shares
Last Trade
Mar 13, 2024 Purchase (Option Exercise)Shares acquired or sold by exercising stock options or converting another derivative security.
$3.29M 23,200 shares
$141.80
$161.44

See more insider trades for free

Join Stockcircle to see more insider trades and be the first to know about new executive transactions.

Sign Up